A judicial panel’s decision to move drug price-fixing lawsuits back to Connecticut underscores a growing trend in states successfully exercising their right to litigate antitrust cases within their own territory.
The US Judicial Panel on Multidistrict Litigation last week denied an attempt by top drugmakers to group the cases into multidistrict litigation in Pennsylvania,
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.